Researchers at UC San Diego, led by Professor Trey Ideker (right) are included in a $142 million initiative from ARPA-H with ...

Roche, hoping to carve out a standard-of-care spot for its PI3K inhibitor Itovebi, now has another leg to stand on with new ...

Assistance from artificial intelligence can potenially increase the number of patients eligible for treatment for HER2-low ...

After a median 34.2 months of follow-up, patients taking Itovebi in combination with Pfizer’s Ibrance and AstraZeneca’s Faslodex survived for a median of 34 months, compared to 27 months for those ...

After a devastating diagnosis, Simone I. Smith and husband LL COOL J sought answers and a new mission to help others ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

Dr Mariana Chavez MacGregor looks ahead to early-stage breast cancer updates, including optimization strategies and emerging approaches to improve patient care.

Sometimes breast cancer can emerge between routine mammograms. Five years after recovery, one patient's story reinforces the ...

CNN anchor and breast cancer patient Sara Sidner, Dr. Vinod Balachandran, and Novartis U.S. president Victor Bulto discussed ...

HealthDay News — Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

Thanks to a new cancer treatment, Lisa Moore of Texarkana was able to beat breast cancer, and new research could provide others with a chance to recover.